Retinal pigment epithelium transplantation: concepts, challenges, and future prospects – (Eye 29, 992 (August 2015))
Retinal pigment epithelium transplantation: concepts, challenges, and future prospects Eye 29, 992 (August 2015). doi:10.1038/eye.2015.89 Authors: P Alexander, H A J Thomson, A J Luff & A J Lotery
MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity – (Eye 29, 1003 (August 2015))
MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity Eye 29, 1003 (August 2015). doi:10.1038/eye.2015.82 Authors: K E Duncan, L Y Chang & M Patronas
Dementia of the eye: the role of amyloid beta in retinal degeneration – (Eye 29, 1013 (August 2015))
Dementia of the eye: the role of amyloid beta in retinal degeneration Eye 29, 1013 (August 2015). doi:10.1038/eye.2015.100 Authors: J A Ratnayaka, L C Serpell & A J Lotery
RNIB call for reversal of NHS England’s decision to block treatments for children and adults with severe refractory uveitis
RNIB have mounted a campaign to ask people to sign up and send messages supporting a reversal of the NHS England’s decision to block treatments for patients with sever refractive uveitis to Simon Stevens and Bruce Keogh at NHS England. In July 2015, NHS England decided they will not routinely provide Humira and Remicade for severe
Eye health indicator figures updated with 2013/14 data
Public Health Outcomes Framework (PHOF) eye health indicator figures have been refreshed and updated with 2013/14 data. These indicators track the rates of three major causes of sight loss including: age related macular degeneration (AMD) – indicator 4.12 i; glaucoma – indicator 4.12.ii; diabetic retinopathy – indicator 4.12.iii; indicator 4.12 iv “preventable sight loss –